You can now read 10 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe



Drugmaker’s dual role as friend, foe

If you’re inclined to be cynical about corporations in general, and about the pharmaceutical industry in particular, the company behind Zohydro is your Exhibit A.

Zohydro ER is the powerful new painkiller that has people on the front lines of the opioid abuse epidemic freaking out, because the high-dose drug is more easily abused than other painkillers and more deadly if you take too much. Some in Congress and 28 attorneys general want the FDA to reverse its approval of the drug, an approval that defied the recommendation of the agency’s scientific advisory panel. Last week, Governor Deval Patrick imposed a ban on Zohydro until a safer form is developed. On Tuesday, a federal judge indicated she would strike down that ban.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week